Good Morning! -What’s for Breakfast?

Latest Media and Entertainment News

• Amy Campbell is recognized by Continental Who's Who February 22, 2019
  COLLEYVILLE, Texas, Feb. 21, 2019 /PRNewswire/ -- Amy Campbell is recognized by Continental Who's Who as a Pinnacle Lifetime Member in the Healthcare field in recognition of her role as Director of Regulatory Affairs at Smith & Nephew Inc. A leader in the medical supply industry, Smith &...
• Digital Realty Raises Quarterly Cash Dividend for Common Stock by 7% to $1.08 per Share February 22, 2019
  SAN FRANCISCO, Feb. 21, 2019 /PRNewswire/ -- Digital Realty (NYSE: DLR), a leading global provider of data center, colocation and interconnection solutions, announced today that its board of directors has authorized quarterly cash dividends for common and preferred stock for the first...
• 4me Recognized as Rising Star in Latest ISG Provider Lens Report February 22, 2019
  PALO ALTO, Calif., Feb. 21, 2019 /PRNewswire/ -- 4me Inc., a SaaS Enterprise Service Management start-up dedicated to improving the success of selective outsourcing, is delighted to announce that it has achieved "Rising Star" status in the latest report from Information Services Group...
• Vail Resorts to Acquire Falls Creek and Hotham Ski Resorts in Victoria, Australia February 22, 2019
  BROOMFIELD, Colo., Feb. 21, 2019 /PRNewswire/ -- Vail Resorts, Inc. (NYSE: MTN) announced today that it has entered into an agreement to purchase the ski fields at Falls Creek Alpine Resort ("Falls Creek") and Hotham Alpine Resort ("Hotham") in Victoria, Australia. Falls Creek, Victoria's ...
• Foresee Pharmaceuticals annonce des résultats préliminaires positifs dans le cadre de son étude de phase 3 en vue de l'homologation du LMIS 25 mg pour le traitement du cancer de la prostate February 22, 2019
  TAIPEI, Taïwan, 22 février 2019 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) (« Foresee »), a annoncé aujourd'hui les résultats préliminaires de son étude clinique de phase 3 du FP-001 LMIS (suspension injectable de mésylate de leuprolide) 25 mg, une étude ouverte portant...